The Novo Nordisk Foundation is partnering with the Danish Refugee Council, UNICEF and the World Diabetes Foundation on three long-term projects that will contribute to creating better opportunities and future prospects for Syrian refugees in Jordan.
Jordan has received an estimated million-plus refugees as a result of the crisis in Syria, many of whom have inadequate access to education and treatment of illness.
The initiative covers two main focus areas
The Foundation wants to contribute to strengthening the competencies of young Syrian refugees through education and other learning opportunities. This will increase their potential to participate in the labour market in Jordan and also possibly in Syria in the long term.
The initiative will also ensure that more refugees and other vulnerable groups in Jordan are offered better services for preventing and treating noncommunicable diseases such as diabetes and cardiovascular diseases. The initiative will also contribute to developing Jordan’s first plan to integrate noncommunicable diseases into the overall humanitarian initiatives.
Read more about the individual projects below.
Novo Nordisk Foundation awards DKK 120 million to improve the future prospects of young Syrian refugees in Jordan
Novo Nordisk Foundation awards DKK 19.9 million to support learning and readiness for education among young Syrian refugees in Jordan
Novo Nordisk Foundation awards DKK 25 million for initiatives to combat noncommunicable diseases among refugees in Jordan
The Foundation has awarded grants of DKK 165 million for the three partnerships. An additional DKK 40 million has also been allocated, for which individual organizations can apply in spring 2020.
Christian Mostrup Scheel, Senior Press Officer, phone: +45 3067 4805, email@example.com